Flephedrone

Flephedrone is a psychoactive drug that is classified as a stimulant. It is also known as 4-Fluoromethcathinone and is a member of the cathinone family. Flephedrone was first synthesized in the year 2008 and has since been available in the recreational drug market.

Chemistry[edit | edit source]

Flephedrone is a fluorine-containing derivative of methcathinone. It has a molecular formula of C10H12FNO and a molar mass of 181.21 g/mol. The compound is a white crystalline powder at room temperature.

Pharmacology[edit | edit source]

Flephedrone acts as a potent serotonin, norepinephrine, and dopamine reuptake inhibitor, thereby increasing the levels of these neurotransmitters in the brain. This results in feelings of euphoria, increased energy, and heightened sensory perception.

Effects[edit | edit source]

The effects of Flephedrone are similar to those of other stimulants and include increased heart rate, increased blood pressure, dilated pupils, and increased body temperature. Users may also experience feelings of euphoria, increased sociability, and heightened sensory perception. However, these effects are often accompanied by negative side effects such as anxiety, paranoia, and insomnia.

Legal Status[edit | edit source]

The legal status of Flephedrone varies by country. In the United States, it is classified as a Schedule I controlled substance, making it illegal to manufacture, distribute, or possess. In the United Kingdom, it is classified as a Class B drug under the Misuse of Drugs Act.

Health Risks[edit | edit source]

Long-term use of Flephedrone can lead to a number of health risks, including heart disease, stroke, and addiction. Additionally, because the drug is often sold in impure form, users may also be at risk of ingesting harmful adulterants.